Clinical Trial: A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Persons
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Inflammatory Gastrointestinal Diseases
Study Type: INTERVENTIONAL
Official Title: A Placebo-controlled, Within-group Randomised, and Double-blind Trial Investigating Safety, Tolerability, and Pharmacokinetics of FE 999301 After Ascending Single and Multiple Doses in Healthy Subject
Brief Summary:
Interleukin (IL)-6 is a cytokine produced in response to infection and tissue damage.IL-6 is believed to act as a key mediator in chronic inflammation and autoimmune diseases such as inflammatory bowel diseases.IL-6 is known to be involved in at least two distinct signalling pathways, classical and trans-signalling.The hypothesis is that classical signalling by IL-6 infers some beneficial effects (e.g. on gut barrier function), while excessive IL-6 trans-signalling may have detrimental effects.Olamkicept (FE…
Read more